Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Shen

Showing results (131-140 of 252) with videos related to

Pageof 26
Sort By:
Annals of Surgical Oncology|January 9, 2007
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisRichard P McQuellon, Suzanne C Danhauer, Gregory B Russell, et al.
Annals of Surgical Oncology|November 18, 2015
Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a RequirementHarveshp D Mogal, Edward A Levine, Nora F Fino, et al.
American Journal of Surgery|November 25, 2022
High-risk liver patients are not associated with adverse events following pancreaticoduodenectomyChristopher W Mangieri, Matthew A Strode, Cristian D Valenzuela, et al.
The American Surgeon|September 11, 2002
Breast cancer recurrences in elderly patients after lumpectomyShuchi Shah, Kimberly Doyle, Ethan M Lange, et al.
Journal of Surgical Oncology|October 26, 2022
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Annals of Surgical Oncology|December 9, 2022
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Journal of Surgical Oncology|March 24, 2012
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC)Katharine E Duckworth, Richard P McQuellon, Gregory B Russell, et al.
The American Surgeon|February 15, 2019
Effect of Negative Pressure Wound Therapy on Wound Complications Post-PancreatectomyMichael P Kuncewitch, Aaron U Blackham, Clancy J Clark, et al.
Pageof 26

Showing results (131-140 of 252) with videos related to

Sort By:
Pageof 26
Annals of Surgical Oncology|January 9, 2007
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisRichard P McQuellon, Suzanne C Danhauer, Gregory B Russell, et al.
Annals of Surgical Oncology|November 18, 2015
Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a RequirementHarveshp D Mogal, Edward A Levine, Nora F Fino, et al.
American Journal of Surgery|November 25, 2022
High-risk liver patients are not associated with adverse events following pancreaticoduodenectomyChristopher W Mangieri, Matthew A Strode, Cristian D Valenzuela, et al.
The American Surgeon|September 11, 2002
Breast cancer recurrences in elderly patients after lumpectomyShuchi Shah, Kimberly Doyle, Ethan M Lange, et al.
Journal of Surgical Oncology|October 26, 2022
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Annals of Surgical Oncology|December 9, 2022
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Journal of Surgical Oncology|March 24, 2012
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC)Katharine E Duckworth, Richard P McQuellon, Gregory B Russell, et al.
The American Surgeon|February 15, 2019
Effect of Negative Pressure Wound Therapy on Wound Complications Post-PancreatectomyMichael P Kuncewitch, Aaron U Blackham, Clancy J Clark, et al.
Pageof 26